Table 1. Patient characteristics at... | American Society of Hematology

Table 1.

Patient characteristics at study entry

	No.	%
Total	92	100
Male/female ratio	42/50
Median age (range), y	46 (28-60)
Stage IV	77	84
Bulky mass (> 5 cm)	47	51
High serum LDH	34	37
“B” symptoms	28	30
BM involvement	74	80
Extranodal sites (other than BM)	51	55
Leukemic disease (lymphocytes > 12 000/mm³)	11	12
ECOG PS ≥ 2	8	9
aaIPI ≥ 2	34	37

	No.	%
Total	92	100
Male/female ratio	42/50
Median age (range), y	46 (28-60)
Stage IV	77	84
Bulky mass (> 5 cm)	47	51
High serum LDH	34	37
“B” symptoms	28	30
BM involvement	74	80
Extranodal sites (other than BM)	51	55
Leukemic disease (lymphocytes > 12 000/mm³)	11	12
ECOG PS ≥ 2	8	9
aaIPI ≥ 2	34	37